We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CSPHF market cap is 154.1M. The company's latest EPS is CNY -0.7029 and P/E is -0.17.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 0 | 0 | 1.04B | 243.72M | 481.36M |
| Operating Income | -1.05B | -1.74B | -1.06B | -1.79B | -903.1M |
| Net Income | -1.75B | -2.31B | -1.22B | -1.92B | -902.68M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 1.63B | 2.95B | 3.76B | 2.27B | 1.64B |
| Total Liabilities | 1.12B | 469.06M | 808.29M | 1.06B | 1.19B |
| Total Equity | 515.33M | 2.48B | 2.95B | 1.21B | 449.33M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | -791.11M | -1.08B | -508.07M | -1.48B | -612.47M |
| Investing | -377.7M | -658.88M | 1.18B | -826.55M | 365.12M |
| Financing | 1.66B | 2.09B | 1.39B | 92.3M | 28.47M |
| Market Cap | 154.1M |
| Price to Earnings Ratio | -0.17 |
| Price to Sales Ratio | 0.32 |
| Price to Cash Ratio | 0.28 |
| Price to Book Ratio | 0.34 |
| Dividend Yield | - |
| Shares Outstanding | 1.28B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -60.85% |
| 52 Week High | 0.3623 |
| 52 Week Low | 0.1194 |
| Spread (Intraday) | 0.11 (48.83%) |
| Company Name | CStone Pharmaceuticals (PK) |
| Address |
the offices of vistra (cayman) limited grand cayman KY1-1205 |
| Website | https://www.cstonepharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
